With recent acquisitions topping $8.3 billion, drugmaker will take the lead in generics.
Most large, multistate class-action lawsuits will be shifted into federal courts.
Scientists trap a carbene inside a cage molecule, stabilizing it at room temperature.
High-yield membrane protein production gets a push from a novel bacterial membrane protein.
Codexis buys Germany's Jülich Fine Chemicals, maker of enzymes and chiral intermediates.
Safe daily dose for human ingestion accepted by EPA will guide cleanup of Superfund sites.
Certain types of seaweed efficiently absorb TNT in contaminated coastal waters.
FDA faces a tough decision over whether to allow Bextra, Celebrex, and Vioxx to remain on the market.
Biochemist Leland Clark Jr. is honored for developing a variety of biosensors.